JWJingwen Wei

Jingwen Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingwen Wei has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel John Siegwart

    Department of Biomedical Engineering, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, USA

    2 shared publications
  • Xu Wang

    Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, University of Texas Southwestern Medical Center, Dallas, USA

    2 shared publications
  • Alexis Pacheco Benitez

    Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, USA

    1 shared publication
  • Alexis Pacheco Benitez

    Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering University of Texas Southwestern Medical Center Dallas Texas USA

    1 shared publication
  • Amogh Vaidya

    Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, USA

    1 shared publication
  • Chuhan Zhang

    Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, USA

    1 shared publication

Latest Publications

  • Open Access

    Esterified Cholesterol Conjugates Enable LNP‐Mediated mRNA Delivery to the Blood–Brain Barrier Following Intravenous Administration

    by Zeru Tian, Xu Wang, Alexis Pacheco Benitez, Erick Guerrero, Yaou Duan, Jingwen Wei, Lukas Farbiak, Daniel J. Siegwart

    The blood–brain barrier (BBB) plays a critical role in maintaining central nervous system homeostasis by regulating molecular and cellular exchange between the brain and peripheral circulation. While most delivery strategies focus on crossing the BBB, targeting brain endothelial cells directly may offer a complementary and more controlled alternative for therapeutic intervention. This study presents a ligand‐free lipid nanoparticle (LNP) platform that enables efficient mRNA delivery to the brain endothelium via systemic administration. A modular synthesis strategy was used to generate a chemically diverse library of cholesterol‐based lipids. Screening of 486 LNPs identified an optimized four‐component formulation consisting of C6O2B2 (novel cholesterol‐based lipid), DODAP, DSPC, and DMG‐PEG, which achieves high transfection efficiency in brain endothelial cells without the incorporation of free cholesterol or disruption of BBB integrity and function, such as those utilized in focused ultrasound (FUS) techniques. This BBB‐targeting LNP platform avoids neuronal and glial transfection, thereby offering a noninvasive, and scalable approach for cerebrovascular gene delivery. The work establishes a new class of cholesterol‐based lipids and provides a foundation for next‐generation RNA therapeutics targeting BBB‐associated diseases.


  • Tunable polymers for polymer–lipid hybrid nanoparticles facilitate controlled organ-selective RNA delivery

    by Xu Wang, Zeru Tian, Alexis Pacheco Benitez, Xiaoyan Bian, Amogh Vaidya, Erick Guerrero, Yehui Sun, Chuhan Zhang, Yaou Duan, Jingwen Wei, et al.

  • Synthetic Strategies of Guanine Derivatives for Self‐Assembly in Supramolecular Chemistry

    by Mengjia Liu, Jingwen Wei

    Guanine analogs are powerful molecular platforms for building functional supramolecular assemblies. Their broad utility stems from an exceptional ability to adopt diverse topologies, self‐assembling into discrete G 4 ‐quartet, G‐quadruplexes, and extended ribbon‐like structures. This structural flexibility underlies their wide range of functional applications. Significant research has focused on chemically modifying guanine derivatives to improve their performance in both aqueous and organic environments, and to make them responsive to external factors such as ionic strength, pH, light, and temperature. These modifications allow the inherent chemical information of guanine to be translated into programmable, higher‐order supramolecular systems. Recent progress has led to exciting advances across fields including supramolecular chemistry and chemical biology. In this review, we highlight these developments and discuss how synthetic modifications and interdisciplinary strategies continue to expand the structural and functional diversity of guanine‐based systems.